Search company, investor...

Founded Year

2015

Stage

Series C | Alive

Total Raised

$78.57M

Last Raised

$55M | 2 yrs ago

About InnovHeart

InnovHeart develops transcatheter mitral valve replacement (TMVR) systems for the treatment of mitral valve disease. Its novel therapeutic system is suitable to replace incompetent mitral valves based on transcatheter technology. ​The company was founded in 2015 and is based in Milano, Italy.

Headquarters Location

Via Giovannino de Grassi 11

Milano, 20123,

Italy

+39 0236515110

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

InnovHeart Patents

InnovHeart has filed 9 patents.

The 3 most popular patent topics include:

  • Cardiac surgery
  • Implants (medicine)
  • Cardiac anatomy
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/25/2019

6/27/2023

Cardiac anatomy, Cardiac surgery, Congenital heart defects, Cardiology, Cardiovascular physiology

Grant

Application Date

7/25/2019

Grant Date

6/27/2023

Title

Related Topics

Cardiac anatomy, Cardiac surgery, Congenital heart defects, Cardiology, Cardiovascular physiology

Status

Grant

Latest InnovHeart News

DIRECT INVESTMENTS - Fondo Nazionale Innovazione - CDP Venture Capital SGR

May 2, 2023

IAMA Therapeutics Iama Therapeutics is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel medicines to make a difference in the lives of children suffering from brain disorders. Intracellular chloride (Cl) homeostasis is impaired in many brain disorders, including autism spectrum disorder and epilepsy, due to dysregulated activity of Cl-transporters. Restoring physiological intracellular Cl homeostasis in the brain by inhibiting the Sodium Potassium Chloride cotransporter 1 (NKCC1) or activating the Sodium Chloride cotransporter 2 (KCC2), members of the same family of transporters but with opposing effects has proven a viable strategy for treating many neurodevelopmental disorders in animal models and clinical studies. We have identified and patented a novel compound class that inhibits NKCC1 with high selectivity and backup and follow-up molecules targeting other cotransporters. We aim to improve the lives of children by promoting intracellular homeostasis and reducing the hyperexcitability of some neuronal cells in pathological conditions." The startup journey IEM is a Data management Platform, a Business Intelligence system for analytical data. The platform is based on a proprietary algorithm; it allows the user to monitor and manage statistics and data coming from many sources, both internal and external to the business. With IEM, e-commerce managers and entrepreneurs can increase margins, implement data driven strategies and understand: who the customers are, how they are acquired, what their habits are and how to improve their retention and growth. Thanks to a flexible user interface and interactive and dynamic charts, users can easily monitor the progress of their E-commerce or online business. IEM analyzes data coming from CMS such as PrestaShop, Magento and WooCommerce combining them with those coming from external sources such as Google Analytics, Google Ads, Facebook Ads, Facebook Insight. The startup journey Innovheart InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. About 2% of the world's population, in fact, suffers from mitral valve dysfunctions, which manifest themselves with the reflux of blood from the left ventricle to the left atrium, due to an anomaly that results in an imperfect coaptation of the mitral flaps during ventricular sistole. Our company mission is to bring patients a novel therapeutic system suitable to replace incompetent Mitral Valves based on a safe, effective, and easy-to-use transcatheter technology. InnovHeart is committed to pursuing this goal with the highest level of quality, minimizing the functional limitations of the competitors’ devices and implanting its technology through a less invasive procedure, avoiding surgical preparation for the patient. The company is currently in clinical trials testing its TMVR Saturn Prosthesis, designed to be consistent with the anatomy of the mitral valve. Saturn is a low-profile prosthetic designed for both Trans-apical and Trans-septal delivery. The startup journey Insoore Insoore is a technological platform that helps insurance and fleet management companies to optimize the claims management process through video-photographic inspections and damage estimations, made by a community of experts in real time and on demand. Insoore’s technology modernizes traditional approaches to making insurance claims. In fact, it streamlines the claims process, eases information collection & related data organization. Insoore’s platform also optimizes the time needed for claims management and costs, as well as reduces fraud. With Insoore, companies can access a community of users available to make certified video-photographic documentation. Hundreds of selected and trained experts are ready to offer to the insured assistance and a better customer experience. The startup journey CREA We founded the company Insurtech MGA Srl, an Insurance and Reinsurance Agency wholesaler. Our business model is b2b2c and is aimed at any player wishing to distribute insurance products. The CREA platform allows intermediaries to streamline the processes of distribution and issuance of policies, managing the budgeting and the completely digital issue, and offers the issuance of a personalized certificate in just a few minutes. The technology we use is the Policy Builder Language, which creates an insurance product from scratch. With the platform we have created a cloud that can give the opportunity for intermediaries to control independently their policies and to have on hand any information and details about policies that have generated and issued, and information about their policy. Thus we accelerate the distribution of insurance products and increase the business of intermediaries. The startup journey IoAgri IoAgri is an innovative web platform, multidevice, cloud, scalable and adaptable to the needs of the farmer or agronomist for farm management. The Business Idea was initially created with the aim of providing agricultural businesses with a useful tool for the simplified compilation of the field book and for the register of phytosanitary treatments; progressively, the same has been transformed, evolving towards a management suite much richer in features and tools for the economic analysis of the company. The project therefore aims to provide the entrepreneur with a tool for monitoring and daily optimization of crop operations in the field, from sowing to harvesting, from irrigation to phytosanitary treatment. It also aims to be a tool at the service of agriculture for sending weather alerts, for warehouse management, for the analysis of all production costs, from machinery to labor, from rentals to fuel. IoAgri aims to be an intuitive management software, within everyone's reach, both for small and medium-sized agricultural entrepreneurs less digitized, thanks to easy-to-consult overviews, and for more structured companies more used to new technologies, thanks to more in-depth technical-economic analyzes. and integration with business decision support systems. The program has in fact been designed and developed to be a natural hub for integration with specialized third-party technological solutions (sensors, satellite analysis, DSS), designed to be accessible from any device, both from the home PC and from the field through a Easy to consult and compile APP for data entry. The objective of the project is in fact to become in the next 12/18 a solution recognized on the market for its usability and at the same time to be a global data collection platform where, to the metrics produced by the traditional interaction between economic operators on the market complement, thanks to the integration with new technologies, those related to environmental parameters, measurements and surveys in the field, drone evidence and crop mapping through satellite systems, becoming a complete, modern, evolved solution to all intents and purposes , for predictive analysis and a valid tool for real-time monitoring of activities and essential decision support for the entrepreneur. The startup journey Italie Italie, acronym of Italian Limited Edition, is an innovative startup born in 2017 with the aim of creating a platform for the enhancement of the excellence of Made in Italy products and craftsmanship as well as for the promotion of the Italian tangible and intangible cultural heritage. Italie is not a simple marketplace but a multi-sided platform with an original textual and iconographic language - around which related cultural and multimedia contents revolve. The digital store offers an international audience certified Made in Italy products, all handmade or autographed, made by the most important Italian master craftsmen, artists and brands.On the Italian Limited Edition platform you can: - purchase, through the e-commerce module, the products of Italian manufacturing excellence, selected from quality supply chains, 100% Italian certificates, in limited series or autographs; - know, through storytelling mechanisms, the territories, the productive chains, the craft skills, putting in relation production, context and culture material and immaterial. The startup journey Kither Biotech Kither Biotech is a pre-clinical stage company developing new therapies for rare pulmonary diseases with high unmet needs. The company leverages its unique expertise in delivery of signal transduction inhibition to the respiratory system, leading to strongly improved delivery to the lung. The key product is a proprietary compound to treat Cystic Fibrosis (CF) with preclinical data showing strong superiority vs. the current market leader, with the potential to radically change the treatment paradigm of CF, a global market projected to grow in excess of $20 billion. The CF program is in pre-clinical phase and a Phase I/IIa clinical trial in early 2022. The pipeline also includes a proprietary a small molecule that has shown strong results in pre-clinical models for Idiopathic Pulmonary Fibrosis (IPF), a lethal orphan disease, and has potential long-term use with COVID-19 patients. The company plans to launch the preclinical phases of the this program in early 2021. The startup journey Memento Memento is a leading toy producer who creates, develops, produces, and markets innovative toys belonging to the S.T.E.A.M., Art, and Craft / DIY and Action Games categories. After distributing over 1MLN of products in more than 25 countries through significant industry distributors, Memento will soon launch online marketing in the United States of America using the Direct to Consumer paradigm. The team's goal is to create S.T.E.A.M. Toys that are attractive to girls aged 6 to 10 and stimulate their interest in Scientific, Technological, Engineering, Artistic / Creative, and Mathematical issues. The company's leading intellectual property is based on a patented game system that uses innovative materials, few drops of water, and a kit of accessories, allowing girls to create rubbery objects in few minutes (jewels, characters, robots, and more). The startup journey MyFoody Anagramma is a company born with the aim of creating digital solutions for the reduction of food waste and the promotion of sustainability. To date, the company has developed two services: Myfoody and Babaco Market. The first is a technological solution to reduce food waste in supermarkets through the traceability of expiring products in the points of sale and increased visibility to end consumers thanks to the Myfoody application. The second is a solution for reducing producers' food waste and consists of a subscription service to receive a box of fruit and vegetables at home with products outside the traditional standards. The startup journey Neuranix Neuranix è una società innovativa che sviluppa e produce dispositivi medici per le persone e gli animali domestici, nell’ambito di Smart&Start. Attraverso l’acquisizione di una nuova tecnologia brevettata e grazie alla collaborazione con specialisti del settore, siamo in grado di sviluppare soluzioni e applicazioni specifiche in campo audiologico, in grado di rispondere alle necessità dell’uomo e dell’animale domestico. Oggi Neuranix è proprietaria di un brevetto in campo audiologico ed altri due sono in fase di approvazione. Questi brevetti sono attualmente applicati in due prodotti; Vet-Wave e Med-Wave. Il primo, sviluppato per l’ambito veterinario, è già in fase di commercializzazione, mentre il secondo, per uso umano, sarà lanciato nella seconda metà del 2021. The startup journey

InnovHeart Frequently Asked Questions (FAQ)

  • When was InnovHeart founded?

    InnovHeart was founded in 2015.

  • Where is InnovHeart's headquarters?

    InnovHeart's headquarters is located at Via Giovannino de Grassi 11, Milano.

  • What is InnovHeart's latest funding round?

    InnovHeart's latest funding round is Series C.

  • How much did InnovHeart raise?

    InnovHeart raised a total of $78.57M.

  • Who are the investors of InnovHeart?

    Investors of InnovHeart include Genextra, Panakes Partners, Indaco Venture Partners, Grand Pharmaceutical and CDP Venture Capital.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.